Clinical Trial Update: Europe-Japan Diagnostic Study for EGFR Testing

View source ↗

Summary

This document reports the completion of the Europe-Japan diagnostic trial NCT01785888 evaluating EGFR testing in patients with advanced non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: AstraZeneca | Conditions: EGFR Mutation Status in aNSCLC Patients (Locally Advanced and/or Metastatic Disease) With Adenocarcinoma and Non-adenocarcinoma Histologies. | Status: COMPLETED